Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment

Valentin Brodszky, P. Bálint, P. Géher, László Hodinka, Gábor Horváth, Éva Koó, Márta Péntek, Anna Polgár, Magdolna Seszták, S. Szántó, I. Újfalussy, L. Gulácsi

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The objectives of this study were to assess the costs of psoriatic arthritis (PsA) in Hungary and to identify key cost drivers among demographic and clinical variables and to compare cost-of-illness of PsA and rheumatoid arthritis (RA). Cross-sectional retrospective survey of 183 consecutive patients from eight rheumatology centres was conducted. Mean direct medical, direct non medical, indirect and total costs were 1,876, 794, 2,904 and 5,574 euros/patient/year, respectively. Total costs were in significant linear relationship with health assessment questionnaire score and psoriatic area severity index. Costs of RA were higher in all domains than of PsA. Our study was the first from the Eastern European region that provides cost-of-illness data on PsA. Our study revealed that functional status and severity of skin symptoms were the key cost drivers. The costs of PsA in Hungary were lower than in the high-income European countries.

Original languageEnglish
Pages (from-to)199-205
Number of pages7
JournalRheumatology International
Volume30
Issue number2
DOIs
Publication statusPublished - Dec 2009

Fingerprint

Psoriatic Arthritis
Rheumatoid Arthritis
Costs and Cost Analysis
Cost of Illness
Hungary
Rheumatology
Cross-Sectional Studies
Demography
Skin
Health

Keywords

  • Cost-of-illness
  • Cross-sectional studies
  • Hungary
  • Psoriatic arthritis
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Cite this

Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment. / Brodszky, Valentin; Bálint, P.; Géher, P.; Hodinka, László; Horváth, Gábor; Koó, Éva; Péntek, Márta; Polgár, Anna; Seszták, Magdolna; Szántó, S.; Újfalussy, I.; Gulácsi, L.

In: Rheumatology International, Vol. 30, No. 2, 12.2009, p. 199-205.

Research output: Contribution to journalArticle

Brodszky, Valentin ; Bálint, P. ; Géher, P. ; Hodinka, László ; Horváth, Gábor ; Koó, Éva ; Péntek, Márta ; Polgár, Anna ; Seszták, Magdolna ; Szántó, S. ; Újfalussy, I. ; Gulácsi, L. / Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment. In: Rheumatology International. 2009 ; Vol. 30, No. 2. pp. 199-205.
@article{da7d9889827d4b9b80b39efca3f9b513,
title = "Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment",
abstract = "The objectives of this study were to assess the costs of psoriatic arthritis (PsA) in Hungary and to identify key cost drivers among demographic and clinical variables and to compare cost-of-illness of PsA and rheumatoid arthritis (RA). Cross-sectional retrospective survey of 183 consecutive patients from eight rheumatology centres was conducted. Mean direct medical, direct non medical, indirect and total costs were 1,876, 794, 2,904 and 5,574 euros/patient/year, respectively. Total costs were in significant linear relationship with health assessment questionnaire score and psoriatic area severity index. Costs of RA were higher in all domains than of PsA. Our study was the first from the Eastern European region that provides cost-of-illness data on PsA. Our study revealed that functional status and severity of skin symptoms were the key cost drivers. The costs of PsA in Hungary were lower than in the high-income European countries.",
keywords = "Cost-of-illness, Cross-sectional studies, Hungary, Psoriatic arthritis, Rheumatoid arthritis",
author = "Valentin Brodszky and P. B{\'a}lint and P. G{\'e}her and L{\'a}szl{\'o} Hodinka and G{\'a}bor Horv{\'a}th and {\'E}va Ko{\'o} and M{\'a}rta P{\'e}ntek and Anna Polg{\'a}r and Magdolna Seszt{\'a}k and S. Sz{\'a}nt{\'o} and I. {\'U}jfalussy and L. Gul{\'a}csi",
year = "2009",
month = "12",
doi = "10.1007/s00296-009-0936-1",
language = "English",
volume = "30",
pages = "199--205",
journal = "Rheumatology International",
issn = "0172-8172",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experiment

AU - Brodszky, Valentin

AU - Bálint, P.

AU - Géher, P.

AU - Hodinka, László

AU - Horváth, Gábor

AU - Koó, Éva

AU - Péntek, Márta

AU - Polgár, Anna

AU - Seszták, Magdolna

AU - Szántó, S.

AU - Újfalussy, I.

AU - Gulácsi, L.

PY - 2009/12

Y1 - 2009/12

N2 - The objectives of this study were to assess the costs of psoriatic arthritis (PsA) in Hungary and to identify key cost drivers among demographic and clinical variables and to compare cost-of-illness of PsA and rheumatoid arthritis (RA). Cross-sectional retrospective survey of 183 consecutive patients from eight rheumatology centres was conducted. Mean direct medical, direct non medical, indirect and total costs were 1,876, 794, 2,904 and 5,574 euros/patient/year, respectively. Total costs were in significant linear relationship with health assessment questionnaire score and psoriatic area severity index. Costs of RA were higher in all domains than of PsA. Our study was the first from the Eastern European region that provides cost-of-illness data on PsA. Our study revealed that functional status and severity of skin symptoms were the key cost drivers. The costs of PsA in Hungary were lower than in the high-income European countries.

AB - The objectives of this study were to assess the costs of psoriatic arthritis (PsA) in Hungary and to identify key cost drivers among demographic and clinical variables and to compare cost-of-illness of PsA and rheumatoid arthritis (RA). Cross-sectional retrospective survey of 183 consecutive patients from eight rheumatology centres was conducted. Mean direct medical, direct non medical, indirect and total costs were 1,876, 794, 2,904 and 5,574 euros/patient/year, respectively. Total costs were in significant linear relationship with health assessment questionnaire score and psoriatic area severity index. Costs of RA were higher in all domains than of PsA. Our study was the first from the Eastern European region that provides cost-of-illness data on PsA. Our study revealed that functional status and severity of skin symptoms were the key cost drivers. The costs of PsA in Hungary were lower than in the high-income European countries.

KW - Cost-of-illness

KW - Cross-sectional studies

KW - Hungary

KW - Psoriatic arthritis

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=71349084706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71349084706&partnerID=8YFLogxK

U2 - 10.1007/s00296-009-0936-1

DO - 10.1007/s00296-009-0936-1

M3 - Article

VL - 30

SP - 199

EP - 205

JO - Rheumatology International

JF - Rheumatology International

SN - 0172-8172

IS - 2

ER -